Manish A. Shah

33.1k total citations · 12 hit papers
336 papers, 17.3k citations indexed

About

Manish A. Shah is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Manish A. Shah has authored 336 papers receiving a total of 17.3k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Pulmonary and Respiratory Medicine, 171 papers in Oncology and 125 papers in Surgery. Recurrent topics in Manish A. Shah's work include Gastric Cancer Management and Outcomes (158 papers), Esophageal Cancer Research and Treatment (70 papers) and Colorectal Cancer Treatments and Studies (49 papers). Manish A. Shah is often cited by papers focused on Gastric Cancer Management and Outcomes (158 papers), Esophageal Cancer Research and Treatment (70 papers) and Colorectal Cancer Treatments and Studies (49 papers). Manish A. Shah collaborates with scholars based in United States, Japan and South Korea. Manish A. Shah's co-authors include Gary K. Schwartz, David P. Kelsen, Yoon‐Koo Kang, Atsushi Ohtsu, Eric Van Cutsem, Laura H. Tang, Daniel G. Coit, Florian Lordick, Mithat Gönen and David Cunningham and has published in prestigious journals such as Nature, Cell and The Lancet.

In The Last Decade

Manish A. Shah

324 papers receiving 17.0k citations

Hit Papers

Cetuximab Shows Activity in Colorectal Cancer Patients Wi... 2005 2026 2012 2019 2005 2011 2017 2005 2015 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
    2005 848 citations Manish A. Shah, David S. Klimstra et al. Journal of Clinical Oncology profile →
  2. Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
    2011 845 citations Atsushi Ohtsu, Manish A. Shah et al. Journal of Clinical Oncology profile →
  3. Oesophageal cancer
    2017 691 citations Florian Lordick, Manish A. Shah et al. profile →
  4. Targeting the Cell Cycle: A New Approach to Cancer Therapy
    2005 660 citations Manish A. Shah et al. Journal of Clinical Oncology profile →
  5. Chemotherapy Use, Performance Status, and Quality of Life at the End of Life
    2015 422 citations Holly G. Prigerson, Manish A. Shah et al. profile →
  6. Gastric cancer epidemiology and risk factors
    2012 413 citations Manish A. Shah et al. profile →
  7. Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
    2017 391 citations Manish A. Shah, Atsushi Ohtsu et al. profile →
  8. Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus
    2018 362 citations Manish A. Shah, Peter C. Enzinger et al. profile →
  9. Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
    2023 342 citations Kohei Shitara, Florian Lordick et al. profile →
  10. Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study
    2018 336 citations Lin Shen, Atsushi Ohtsu et al. profile →
  11. Dietary fructose improves intestinal cell survival and nutrient absorption
    2021 194 citations Manish A. Shah et al. profile →
  12. Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline
    2020 181 citations Manish A. Shah, Laura H. Tang et al. Journal of Clinical Oncology profile →

Peers

Manish A. Shah
Comparison fields: 5 of 159
  • Oncology 8.9k
  • Pulmonary and Respiratory Medicine 8.0k
  • Surgery 5.2k
  • Molecular Biology 4.1k
  • Gastroenterology 2.2k
Replace Lin Shen with:
Lin Shen China
Hye Seung Lee South Korea
Sun Young Rha South Korea
Stefano Cascinu Italy
Yoshihiro Kakeji Japan
Piotr Rutkowski Poland
Jiafu Ji China
Donato Nitti Italy
Daniel G. Haller United States
Evelien Dekker Netherlands
Lin Shen China View profile →
Citations per field, relative to Manish A. Shah
Manish A. Shah · 1×
Citations per year, relative to Manish A. Shah
Manish A. Shah · 1×

Countries citing papers authored by Manish A. Shah

Since Specialization
Citations

This map shows the geographic impact of Manish A. Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manish A. Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manish A. Shah more than expected).

Fields of papers citing papers by Manish A. Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manish A. Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manish A. Shah. The network helps show where Manish A. Shah may publish in the future.

Co-authorship network of co-authors of Manish A. Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Manish A. Shah. A scholar is included among the top collaborators of Manish A. Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manish A. Shah. Manish A. Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
8MO Neoadjuvant botensilimab (BOT) plus balstilimab (BAL) in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial
2024 ·Annals of Oncology ·(unknown), Mehraneh D. Jafari, Heather Yeo, Lea Lowenfeld, Uzma Khan, (unknown), Despina Siolas, (unknown), (unknown), (unknown), Allyson J. Ocean, E Popa, Kelly A. Garrett, (unknown), (unknown), Xi Kathy Zhou, Alessio Pigazzi, Manish A. Shah, Erika Hissong, (unknown)
4
2
LEAP-014: first-line lenvatinib + pembrolizumab + chemotherapy in advanced/metastatic esophageal squamous cell carcinoma
2024 ·Future Oncology ·Jong‐Mu Sun, Antoine Adenis, Peter C. Enzinger, Manish A. Shah, Ken Kato, Jaafar Bennouna, Toshihiko Doi, Natalyn Hawk, Li Yu, Sukrut Shah, Pooja Bhagia, Lin Shen
2
3
Final overall survival results from phase 3 SPOTLIGHT study evaluating zolbetuximab + mFOLFOX6 as first-line (1L) treatment for patients (pts) with claudin 18 isoform 2 (CLDN18.2)+, HER2−, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma.
2024 ·Journal of Clinical Oncology ·Kohei Shitara, Eric Van Cutsem, Florian Lordick, Peter C. Enzinger, David H. Ilson, Manish A. Shah, Rui‐Hua Xu, Sara Lonardi, Kensei Yamaguchi, (unknown), Bożena Kukiełka-Budny, (unknown), Maria Matsangou, Ran Li, Diarmuid Moran, (unknown), (unknown), Jaffer A. Ajani
4
4
134MO Updated efficacy and safety results from phase III GLOW study evaluating zolbetuximab + CAPOX as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2−, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma
2023 ·Annals of Oncology ·Florian Lordick, Manish A. Shah, Kohei Shitara, Jaffer A. Ajani, Y-J. Bang, Peter C. Enzinger, David H. Ilson, (unknown), Javier Gállego, Jee‐Fu Huang, Lin Shen, Sang Cheul Oh, Patrapim Sunpaweravong, (unknown), Hacı Mehmet Türk, J.W. Park, Diarmuid Moran, P. Bhattacharya, Yue Cao, (unknown)
2
5
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer
2023 ·Journal for ImmunoTherapy of Cancer ·Ronan J. Kelly, Katherine M. Bever, Joseph Chao, Kristen K. Ciombor, Cathy Eng, Marwan Fakih, Lipika Goyal, Joleen M. Hubbard, Renuka Iyer, Holly Kemberling, Smitha Krishnamurthi, Geoffrey Y. Ku, (unknown), Van K. Morris, Andrew Scott Paulson, (unknown), Manish A. Shah, Dung T. Le
14
6
Prevalence and antimicrobial susceptibility of Acinetobacter spp. in a tertiary care hospital in Peshawar: a cross-sectional study
2023 ·Annals of Medicine and Surgery ·Shahzad Ahmad, (unknown), Faheemullah Khan, Hassan Mumtaz, Wiqar Ahmad, Manish A. Shah, Izaz Ahmad, (unknown), (unknown), (unknown), (unknown)
2
7
Circulating IgA Antibodies Against Fusobacterium nucleatum Amyloid Adhesin FadA are a Potential Biomarker for Colorectal Neoplasia
2022 ·Cancer Research Communications ·Jung Eun Baik, Li Li, Manish A. Shah, Daniel E. Freedberg, Zhezhen Jin, Timothy C. Wang, Yiping W. Han
11
8
Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage
2021 ·Communications Biology ·Ada Gjyrezi, Giuseppe Galletti, Jiaren Zhang, Daniel Worroll, Michael Sigouros, (unknown), Victoria Cooley, Karla V. Ballman, Allyson J. Ocean, Manish A. Shah, Joseph M. Scandura, Andrea Sboner, David M. Nanus, Himisha Beltran, Scott T. Tagawa, Paraskevi Giannakakou
5
9
Microtubule Engagement with Taxane Is Altered in Taxane-Resistant Gastric Cancer
2020 ·Clinical Cancer Research ·Giuseppe Galletti, Chao Zhang, Ada Gjyrezi, (unknown), Jiaren Zhang, Sarah Powell, Prashant V. Thakkar, Doron Betel, Manish A. Shah, Paraskevi Giannakakou
24
10
COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study
2020 ·Journal of Clinical Oncology ·Gagandeep Brar, Laura C. Pinheiro, (unknown), (unknown), Evgeniya Reshetnyak, Orysya Soroka, Frank Chen, (unknown), John L. Vaughn, Peter Martin, Doru Paul, Manuel Hidalgo, Manish A. Shah
77
11
Associations between Anxiety, Poor Prognosis, and Accurate Understanding of Scan Results among Advanced Cancer Patients
2019 ·Journal of Palliative Medicine ·Heather M. Derry, Paul K. Maciejewski, Andrew S. Epstein, Manish A. Shah, Thomas W. LeBlanc, Valerie F. Reyna, Holly G. Prigerson
24
12
Palliative Chemotherapy or Radiation and Prognostic Understanding among Advanced Cancer Patients: The Role of Perceived Treatment Intent
2019 ·Journal of Palliative Medicine ·Login S. George, Holly G. Prigerson, Andrew S. Epstein, Kristy L. Richards, Megan Johnson Shen, Heather M. Derry, Valerie F. Reyna, Manish A. Shah, Paul K. Maciejewski
16
13
A new approach for advanced gastric cancer: Using PET scans as a biomarker of preoperative chemotherapy efficacy.
2017 ·PubMed ·Manish A. Shah, Vivian E. Strong, Judy C. Boughey
1
14
Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response
2016 ·Clinical Cancer Research ·Bryan J. Schneider, Manish A. Shah, Kelsey Klute, Allyson J. Ocean, E Popa, Nasser K. Altorki, Michael W. Lieberman, Andrew M. Schreiner, Rhonda K. Yantiss, Paul J. Christos, (unknown), Daoqi You, Agnès Viale, Pouneh Kermani, Joseph M. Scandura
51
15
First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors
2015 ·Clinical Cancer Research ·Alexander Starodub, Allyson J. Ocean, Manish A. Shah, Michael J. Guarino, Vincent J. Picozzi, Linda T. Vahdat, Sajeve Thomas, Serengulam V. Govindan, Pius Maliakal, William A. Wegener, Steven A. Hamburger, Robert M. Sharkey, David M. Goldenberg
252
16
Prognostic Role of Lemur Tyrosine Kinase-3 Germline Polymorphisms in Adjuvant Gastric Cancer in Japan and the United States
2013 ·Molecular Cancer Therapeutics ·Takeru Wakatsuki, Melissa J. LaBonte, Pierre Bohanes, Wu Zhang, Dongyun Yang, Mizutomo Azuma, Afsaneh Barzi, Yan Ning, Fotios Loupakis, (unknown), (unknown), Sebastian Stintzing, Rita El‐Khoueiry, Wasaburo Koizumi, Masahiko Watanabe, Manish A. Shah, Justin Stebbing, Georgios Giamas, Heinz‐Josef Lenz
18
17
Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial
2012 ·Journal of Clinical Oncology ·Eric Van Cutsem, Sanne de Haas, Yoon‐Koo Kang, Atsushi Ohtsu, Niall C. Tebbutt, Jianming Xu, Wei Peng Yong, Bernd Langer, Paul Delmar, Stefan Scherer, Manish A. Shah
358
18
Molecular Classification of Gastric Cancer: A New Paradigm
2011 ·Clinical Cancer Research ·Manish A. Shah, Raya Khanin, Laura H. Tang, Yelena Y. Janjigian, David S. Klimstra, Hans Gerdes, David P. Kelsen
235
19
A role for macroautophagy in protection against 4-hydroxytamoxifen–induced cell death and the development of antiestrogen resistance
2008 ·Molecular Cancer Therapeutics ·Julia S. Samaddar, (unknown), Jennifer Duplantier, (unknown), Manish A. Shah, (unknown), Darren D. Browning, James V. Rawson, Sylvia B. Smith, John T. Barrett, Patricia V. Schoenlein
162
20
[Thalamic bleeding--its C.T. findings and treatment (author's transl)].
1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Tetsuo Kanno, Kazuhiro Katada, (unknown), Manish A. Shah, Katsuhiro Sano
3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lin Shen Breakdown of academic impact, for papers by Hye Seung Lee Breakdown of academic impact, for papers by Sun Young Rha Breakdown of academic impact, for papers by Stefano Cascinu Breakdown of academic impact, for papers by Yoshihiro Kakeji Breakdown of academic impact, for papers by Piotr Rutkowski Breakdown of academic impact, for papers by Jiafu Ji Breakdown of academic impact, for papers by Donato Nitti Breakdown of academic impact, for papers by Daniel G. Haller Breakdown of academic impact, for papers by Evelien Dekker
Rankless by CCL
2026